Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/8/26 16:15 | 9/4/26 | DYN | Health | Drug | Pharmaceutical Preparations | Friedl-Naderer Johanna | MA | O | Chief Co | 2 | S.m | -31 | 23.91 | 0 | -1 | 154 | D | |||||||||||||||
9/8/26 16:14 | 9/4/26 | DYN | Health | Drug | Pharmaceutical Preparations | Kerr Douglas | MA | O | Chief Me | 2 | S.m | -156 | 23.74 | 0 | -7 | 168 | D | |||||||||||||||
9/8/26 16:13 | 9/8/26 | DYN | Health | Drug | Pharmaceutical Preparations | Cox John | MA | DO | CEO,P | 2 | S | -238 | 22.35 | 0 | -11 | 435 | D | |||||||||||||||
8/17/26 17:30 | 8/13/26 | DYN | Health | Drug | Pharmaceutical Preparations | Rhodes Jason P | MA | D | 4 | S.m | -99,402 | 24.03 | 0 | -4,137 | 1,089 | I | ||||||||||||||||
8/17/26 16:06 | 8/13/26 | DYN | Health | Drug | Pharmaceutical Preparations | Lucera Erick | MA | O | CFO | 2 | S | -95 | 22.92 | 0 | -4 | 122 | D | |||||||||||||||
7/29/26 16:15 | 7/27/26 | DYN | Health | Drug | Pharmaceutical Preparations | Kersten Dirk | MA | D | 3 | S.m | -13,831 | 22.68 | 0 | -610 | 4,112 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |